Tourette Syndrome (Central Nervous System) Market 2021 Size, Status and Industry Outlook 2026

The Tourette Syndrome (Central Nervous System) Market report offers an in-depth assessment of market dynamics, the competitive landscape, segments, and regions in order to help readers to become familiar with the Tourette Syndrome (Central Nervous System) market. It particularly sheds light on market fluctuations, pricing structure, uncertainties, potential risks, and growth prospects to help players to plan effective strategies for gaining successful in the Tourette Syndrome (Central Nervous System) market. Importantly, it allows players to gain deep insights into the business development and market growth of leading companies operating in the Tourette Syndrome (Central Nervous System) market.

Get a Free Sample Copy of This Report:

https://www.marketinsightsreports.com/reports/11023647165/tourette-syndrome-central-nervous-system-drugs-in-development-2021/inquiry?Mode=namita

Top Leading Companies of Tourette Syndrome (Central Nervous System) Market are - Adeptio Pharmaceuticals Ltd, Asarina Pharma AB, Emalex Biosciences Inc, Evero Health Ltd, Noema Pharma AG, Octapharma AG, SOM Biotech SL, Teva Pharmaceutical Industries Ltd, and others.

Industry News and Updates:

Emalex Biosciences Announces Completion of Patient Enrollment in Phase 2b Clinical Trial Evaluating Ecopipam (EBS-101) for Pediatric Patients with Tourette Syndrome

CHICAGO, June 22, 2021-- Emalex Biosciences, Inc. ("Emalex"), a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system movement disorders and fluency disorders, announced today that its Phase 2b clinical trial evaluating the efficacy and safety of ecopipam (EBS-101) for the treatment of pediatric patients with Tourette Syndrome has reached 100% percent enrollment. The clinical trial, known as the D1AMOND Study (NCT04007991), is a 12-week randomized, double-blind, placebo controlled parallel-group study that enrolled 153 patients globally.  An interim futility analysis conducted in March 2021 by an Independent Data Monitoring Committee on the first 75 patients enrolled recommended that the trial continue as planned, as it appeared to be adequately powered and no safety signal was evident that would cause a study modification.  Full trial results are expected by the end of the year.  

Market Overview:

Tourette syndrome (TS) is a neurological disorder characterized by repetitive, stereotyped, involuntary movements and vocalizations called tics. Symptoms include eye blinking and other eye movements, facial grimacing, shoulder shrugging, and head or shoulder jerking. Other symptoms include touching the nose, smelling objects, flapping the arms and hopping. The predisposing factors include age. Males are about three to four times more likely than females to develop Tourette syndrome. Treatment includes antidepressants, stimulant medications and behavior therapy.

Investigator Observers Strong Growth in Specific Regions:

– Europe Market (Germany, UK, France, Russia, Italy)

– Center East and Africa Market (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)

– South America Market (Brazil, Argentina, Colombia)

– North America Market (United States, Canada, Mexico)

– Asia Pacific Market (China, Japan, Korea, India, Southeast Asia).

Scope of Tourette Syndrome (Central Nervous System) Market Report:

- The report provides a snapshot of the global therapeutic landscape of Tourette Syndrome (Central Nervous System).
- The report reviews product therapeutics for Tourette Syndrome (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The report covers the products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The report features descriptive drug profiles for the products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The report reviews key companies involved in Tourette Syndrome (Central Nervous System) maket therapeutics and enlists all their major and minor projects.
- The report evaluates Tourette Syndrome (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The report encapsulates all the dormant and discontinued pipeline projects.
- The report reviews latest news related to the product therapeutics for Tourette Syndrome (Central Nervous System)

Browse Full Report at:

https://www.marketinsightsreports.com/reports/11023647165/tourette-syndrome-central-nervous-system-drugs-in-development-2021?Mode=namita

Reasons to Buy This Report:

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Tourette Syndrome (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for market projects by understanding Tourette Syndrome (Central Nervous System) depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from market.

We Offer Customization on Report Based on Specific Client Requirement:

- Country Level analysis for any 5 countries of your choice.

- Competitive analysis of any 5 key market players.

- 40 analyst hours to cover any other data point.

Contact Us:
Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

About Us:

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.